aDivision of Surgical Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center, 

bDepartment of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope Medical Center, 

cDepartment of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, 

dDepartment of Radiology, City of Hope, 

eDepartment of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, California, 

fDepartment of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, 

gDepartment of Biostatistics, Beckman Research Institute, Duarte, California, 

hDivision of Surgical Oncology, Department of Surgery, UK Healthcare, University of Kentucky, Lexington, Kentucky and 

iDepartment of Immunology, Beckman Research Institute, City of Hope, Duarte, California, USA

Received 7 March 2023 Accepted 30 August 2023.

Correspondence to Yanghee Woo, MD, Division of Surgical Oncology, Department of Surgery, Theranostic Modality, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA, Tel: +1 626 218 0220; fax: +1 626 218 8113; e-mail: [email protected]